Cargando…

Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin

Glutathione is the major intracellular anti-oxidant against reactive oxygen species and serves as a detoxification essential. The anti-diabetic drug metformin has been showed to exert anti-tumor activity via modulation of redox homeostasis. In this study, we provided evidence that metformin inhibits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Pin Dong, Liu, Zhao, Cheng, Tian Tian, Luo, Wen Guang, Yao, Jing, Chen, Jing, Zou, Zhen Wei, Chen, Li Li, Ma, Charlie, Dai, Xiao Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617486/ https://www.ncbi.nlm.nih.gov/pubmed/28977926 http://dx.doi.org/10.18632/oncotarget.18907

Ejemplares similares

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2023)

Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions
por: Yu, Hongliang, et al.
Publicado: (2016)

Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin
por: Wang, Feng, et al.
Publicado: (2017)

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1
por: Li, Pin-Dong, et al.
Publicado: (2017)

Metformin potentiates rapamycin and cisplatin in gastric cancer in mice
por: Yu, Yu, et al.
Publicado: (2015)

Nipped-B-like Protein Sensitizes Esophageal Squamous Cell Carcinoma Cells to Cisplatin via Upregulation of PUMA
por: Zhang, Shengjie, et al.
Publicado: (2020)

Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
por: Yu, Xinfang, et al.
Publicado: (2017)

Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma
por: Li, Yuxi, et al.
Publicado: (2022)

eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016)

CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis
por: Tian, Tian, et al.
Publicado: (2022)

Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation
por: Zhang, Hongfang, et al.
Publicado: (2015)

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
por: Cui, Wei, et al.
Publicado: (2020)

Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells
por: Chen, Chuangui, et al.
Publicado: (2017)

Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
por: Zhang, Liangze, et al.
Publicado: (2017)

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Shi, Yan, et al.
Publicado: (2013)

Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway
por: Yang, Yi, et al.
Publicado: (2017)

Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma
por: Han, Xinghua, et al.
Publicado: (2017)

Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
por: Hou, Guiqin, et al.
Publicado: (2014)

RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes
por: Zeng, Rui‐Jie, et al.
Publicado: (2019)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
por: Ding, Wen-Xiu, et al.
Publicado: (2019)

Hexokinase 2 Depletion Confers Sensitization to Metformin and Inhibits Glycolysis in Lung Squamous Cell Carcinoma
por: Guo, Wenzheng, et al.
Publicado: (2020)

Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction
por: Wu, Hua-Tao, et al.
Publicado: (2020)

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
por: XIE, YA, et al.
Publicado: (2014)

Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway
por: He, Yindi, et al.
Publicado: (2018)

Contribution of KCTD12 to esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2018)

miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin
por: Tian, Hang, et al.
Publicado: (2022)

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells
por: Cheng, Xiao-Yu, et al.
Publicado: (2017)

Integrin-linked kinase affects the sensitivity of esophageal squamous cell carcinoma cells to chemotherapy with cisplatin via the Wnt/beta-catenin signaling pathway
por: Xu, Ting, et al.
Publicado: (2022)

Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma
por: Xie, Fajun, et al.
Publicado: (2011)

Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
por: Yang, Chen, et al.
Publicado: (2019)

m(6)A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
por: Xiao, Dong, et al.
Publicado: (2021)

Hypoglycemic encephalopathy caused by overdose of metformin in an adolescent
por: Li, Jing-Xue, et al.
Publicado: (2020)

Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities
por: Riaz, Muhammad Assad, et al.
Publicado: (2019)

Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT
por: Zhou, Hong-Hao, et al.
Publicado: (2016)

The prognostic effect of perineural invasion in esophageal squamous cell carcinoma
por: Chen, Jie-Wei, et al.
Publicado: (2014)

Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Zhang, Peng, et al.
Publicado: (2016)

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma
por: Song, Kewei, et al.
Publicado: (2023)

Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinoma
por: Yamada, Moyuru, et al.
Publicado: (2023)

Contribution of dysregulated circRNA_100876 to proliferation and metastasis of esophageal squamous cell carcinoma
por: Cao, Sai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ku5ccdd80v2v5lb9ocmdmo3fab